Exact Mass: 615.2500082
Exact Mass Matches: 615.2500082
Found 118 metabolites which its exact mass value is equals to given mass value 615.2500082
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Paromomycin
Paromomycin is only found in individuals that have used or taken this drug. It is an oligosaccharide antibiotic produced by various streptomyces. [PubChem]Paromomycin inhibits protein synthesis by binding to 16S ribosomal RNA. Bacterial proteins are synthesized by ribosomal RNA complexes which are composed of 2 subunits, a large subunit (50s) and small (30s) subunit, which forms a 70s ribosomal subunit. tRNA binds to the top of this ribosomal structure. Paramomycin binds to the A site, which causes defective polypeptide chains to be produced. Continuous production of defective proteins eventually leads to bacterial death. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID P126
Paromomycin I
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
Dicaffeoyl Coumaroyl Spermidine
C34H37N3O8 (615.2580522000001)
Annotation level-3
(+/-)-8-(p-hydroxybenzyl)-2,3,10,11-tetrahydroxyprotoberberine pentaacetate|8-(p-hydroxybenzyl)-2,3,10,11-tetrahydroxyprotoberberine penta-O-acetate
Asp Arg Tyr Tyr
Asp Tyr Arg Tyr
Asp Tyr Tyr Arg
Phe Met Arg Tyr
C29H41N7O6S (615.2838886000001)
Phe Met Tyr Arg
C29H41N7O6S (615.2838886000001)
Phe Arg Met Tyr
C29H41N7O6S (615.2838886000001)
Phe Arg Tyr Met
C29H41N7O6S (615.2838886000001)
Phe Thr Trp Tyr
Phe Thr Tyr Trp
Phe Trp Thr Tyr
Phe Trp Tyr Thr
Phe Tyr Met Arg
C29H41N7O6S (615.2838886000001)
Phe Tyr Arg Met
C29H41N7O6S (615.2838886000001)
Phe Tyr Thr Trp
Phe Tyr Trp Thr
His His His Trp
His His Trp His
His Trp His His
Met Phe Arg Tyr
C29H41N7O6S (615.2838886000001)
Met Phe Tyr Arg
C29H41N7O6S (615.2838886000001)
Met Arg Phe Tyr
C29H41N7O6S (615.2838886000001)
Met Arg Tyr Phe
C29H41N7O6S (615.2838886000001)
Met Tyr Phe Arg
C29H41N7O6S (615.2838886000001)
Met Tyr Arg Phe
C29H41N7O6S (615.2838886000001)
Pro Gln Trp Trp
Pro Trp Gln Trp
Pro Trp Trp Gln
Gln Pro Trp Trp
Gln Trp Pro Trp
Gln Trp Trp Pro
Arg Asp Tyr Tyr
Arg Phe Met Tyr
C29H41N7O6S (615.2838886000001)
Arg Phe Tyr Met
C29H41N7O6S (615.2838886000001)
Arg Met Phe Tyr
C29H41N7O6S (615.2838886000001)
Arg Met Tyr Phe
C29H41N7O6S (615.2838886000001)
Arg Tyr Asp Tyr
Arg Tyr Phe Met
C29H41N7O6S (615.2838886000001)
Arg Tyr Met Phe
C29H41N7O6S (615.2838886000001)
Arg Tyr Tyr Asp
Thr Phe Trp Tyr
Thr Phe Tyr Trp
Thr Trp Phe Tyr
Thr Trp Tyr Phe
Thr Tyr Phe Trp
Thr Tyr Trp Phe
Trp Phe Thr Tyr
Trp Phe Tyr Thr
Trp His His His
Trp Pro Gln Trp
Trp Pro Trp Gln
Trp Gln Pro Trp
Trp Gln Trp Pro
Trp Thr Phe Tyr
Trp Thr Tyr Phe
Trp Trp Pro Gln
Trp Trp Gln Pro
Trp Tyr Phe Thr
Trp Tyr Thr Phe
Tyr Asp Arg Tyr
Tyr Asp Tyr Arg
Tyr Phe Met Arg
C29H41N7O6S (615.2838886000001)
Tyr Phe Arg Met
C29H41N7O6S (615.2838886000001)
Tyr Phe Thr Trp
Tyr Phe Trp Thr
Tyr Met Phe Arg
C29H41N7O6S (615.2838886000001)
Tyr Met Arg Phe
C29H41N7O6S (615.2838886000001)
Tyr Arg Asp Tyr
Tyr Arg Phe Met
C29H41N7O6S (615.2838886000001)
Tyr Arg Met Phe
C29H41N7O6S (615.2838886000001)
Tyr Arg Tyr Asp
Tyr Thr Phe Trp
Tyr Thr Trp Phe
Tyr Trp Phe Thr
Tyr Trp Thr Phe
Tyr Tyr Asp Arg
Tyr Tyr Arg Asp
Thymolphthalein monophosphate 2-amino-2-methyl-1,3-propanediol salt
(5R-(5alpha,5abeta,8aalpha,9beta))-9-((2-Deoxy-2-(dimethylamino)-4,6-O-ethylidene-β-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3,4:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
C31H37NO12 (615.2315642000001)
3-[7-[2-(Cyclopropylmethoxy)-6-[(4-methoxyphenyl)methoxy]phenyl]-1,4-dihydro-2-oxo-2H-pyrido[2,3-d][1,3]oxazin-5-yl]-1-piperidinecarboxylic acid tert-butyl ester
Butamben picrate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
N-[(4R,7R,8S)-5-(benzenesulfonyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methylbenzenesulfonamide
C30H37N3O7S2 (615.2072812000001)
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[[(2R,3S,4R,5R)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[[(3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]oxy]oxane-3,4-diol
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2S,3S,5R,6S)-3,5-diamino-2-[(3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol
5-aminopentyl beta-D-glucopyranosyl-(1->3)-2-O-acetyl-6-deoxy-alpha-L-talopyranosyl-(1->3)-beta-D-glucopyranoside
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5R)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol
(2R,3R,4S,5S,6S)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5R)-5-[(1S,2S,3R,5S,6R)-3,5-diamino-2-[(2R,3S,4S,5R,6S)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol
Paromomycin
An amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer). It is obtained from various Streptomyces species. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
(2e)-n-[(1e)-7-[(3-aminopropyl)amino]-1-(3,4-dihydroxyphenyl)-3-oxohept-1-en-4-yl]-3-(3,4-dihydroxyphenyl)-n-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]prop-2-enamide
C34H37N3O8 (615.2580522000001)
(2r,3s,4r,5r,6r)-5-amino-6-{[(2r,3s,4r,5s)-5-{[(1r,2r,3s,5r,6s)-3-amino-2-{[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-5,6-dihydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}-2-(aminomethyl)oxane-3,4-diol
(2s,3r,4s,5s,6r)-5-amino-6-{[(2r,3s,4r,5s)-5-{[(1r,2r,3s,5r,6s)-3-amino-2-{[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-5,6-dihydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}-2-(aminomethyl)oxane-3,4-diol
4-(dimethylamino)-6-(11-hydroxy-5-methyl-2-{2-methyl-3-[(1e)-prop-1-en-1-yl]oxiran-2-yl}-4,7,12-trioxo-1-oxatetraphen-10-yl)-2,4-dimethyloxan-3-yl acetate
8-(acetyloxy)-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-4-yl benzoate
C32H41NO11 (615.2679476000001)